Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosrenol vs Sevelamer in Hemodialysis Patients
NCT00441545Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Takeda. Started Jan 2007; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00441545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441545.